PITUITARY ADENYLATE CYCLASE ACTIVATING
PITUITARY ADENYLATE CYCLASE ACTIVATING Basic information
- Product Name:
- PITUITARY ADENYLATE CYCLASE ACTIVATING
- Synonyms:
-
- Pacap (6-27)-human
- PITUITARY ADENYLATE CYCLASE ACTIVATING
- pacap-6-27
- pituitary adenylate cyclase activating polypeptide amide fragment 6-27
- Pituitary Adenylate Cyclase Activating Polypeptide-27 (6-27) (huMan, chicken, Mouse, ovine, porcine, rat)
- L-Leucinamide, L-phenylalanyl-L-threonyl-L-α-aspartyl-L-seryl-L-tyrosyl-L-seryl-L-arginyl-L-tyrosyl-L-arginyl-L-lysyl-L-glutaminyl-L-methionyl-L-alanyl-L-valyl-L-lysyl-L-lysyl-L-tyrosyl-L-leucyl-L-alanyl-L-alanyl-L-valyl-
- Human PACAP(6-27)
- PACAP-27 (6-27)
- CAS:
- 136134-68-4
- MF:
- C121H193N33O31S
- MW:
- 2638.09
- Mol File:
- 136134-68-4.mol
More
Less
PITUITARY ADENYLATE CYCLASE ACTIVATING Chemical Properties
- storage temp.
- −20°C
- form
- Solid
- color
- White to off-white
- Sequence
- Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-NH2
More
Less
PITUITARY ADENYLATE CYCLASE ACTIVATING Usage And Synthesis
Uses
PACAP (6-27) (human, ovine, rat) is a PACAP receptor antagonist that blocks the canine adrenal catecholamine response to exogenous vasoactive intestinal peptide (VIP). PACAP (6-27) (human, ovine, rat) has the potential to study cardiovascular and neurological diseases[1].
References
[1] Gaspo R, et al. Canine adrenal catecholamine response to VIP is blocked by PACAP-(6-27) in vivo. Am J Physiol. 1997 May;272(5 Pt 2):R1606-12. DOI:10.1152/ajpregu.1997.272.5.R1606
PITUITARY ADENYLATE CYCLASE ACTIVATINGSupplier
Shanghai Hanhong Scientific Co.,Ltd.
- Tel
- 021-54306202 13764082696
- info@hanhongsci.com
Chemsky (shanghai) International Co.,Ltd
- Tel
- 021-50135380
- shchemsky@sina.com
Cellmano Biotech Limited
- Tel
- 0551-65326643 18156095617
- info@cellmano.com
BOC Sciences
- Tel
- 1-631-485-4226; 16314854226
- info@bocsci.com
Nanjing Leon Biological Technology Co., Ltd.
- Tel
- 17705183659
- sales@njleonbiotech.com